Man Group’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-250,276
Closed -$320K 2416
2025
Q3
$320K Buy
+250,276
New +$339K ﹤0.01% 1980
2024
Q2
Sell
-31,500
Closed -$118K 2207
2024
Q1
$118K Sell
31,500
-4,501
-13% -$26.4K ﹤0.01% 2057
2023
Q4
$353K Buy
+36,001
New +$294K ﹤0.01% 1776
2023
Q3
Sell
-483,580
Closed -$5.53M 572
2023
Q2
$6.43M Buy
+483,580
New +$5.88M 0.02% 776
2022
Q2
Hold
0
1911
2021
Q3
Sell
-12,711
Closed -$444K 2037
2021
Q2
$444K Sell
12,711
-149,350
-92% -$4.34M ﹤0.01% 1595
2021
Q1
$5.4M Sell
162,061
-91,521
-36% -$3.2M 0.02% 651
2020
Q4
$6.58M Buy
+253,582
New +$4.31M 0.03% 646
2020
Q3
Sell
-25,315
Closed -$87K 1851
2020
Q2
$87K Buy
+25,315
New +$86.2K ﹤0.01% 1638
2020
Q1
Sell
-785,846
Closed -$4.04M 1817
2019
Q4
$4.04M Sell
785,846
-516,046
-40% -$2.62M 0.01% 1074
2019
Q3
$6.72M Sell
1,301,892
-236,517
-15% -$1.32M 0.03% 739
2019
Q2
$9.31M Buy
1,538,409
+849,048
+123% +$5.95M 0.03% 661
2019
Q1
$4.98M Buy
+689,361
New +$4.99M 0.02% 925

Other funds holding PACB